Windhover.com | Medtech Insight | The RPM Report | Inteleos | EBI
Subscriber Username:   Password: Forgot Password?
Health Care Business Intelligence, Analysis, Insight - Windhover
Search


Receive Windhover's unique market insight fast with our free alert service 'Windhover's Update', including the latest abstracts and summaries from:

• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight


Sign up now


IN VIVO: The Business and Medicine Report
IN VIVO

IN VIVO is the premier strategic business resource for the biopharma, medtech, and diagnostics industries.

IN VIVO delivers:

  • Revealing, in-depth coverage of your competitors' strategies
  • Incisive projections of future industry trends and their implications for your business
  • Expert analysis of key industry developments
  • Exclusive interviews with top industry executives and analysts
  • In-depth examination of dealmaking, marketing, R&D, regulatory, and finance strategies -- those that were successful and those that missed the mark

Includes FREE subscription to Health News Daily

Subscribe Subscribe w/ archive Renew Subscription Latest Issue Subscription Agreement Search Articles Sample Issue


START-UP: Emerging Medical Ventures
Start-Up START-UP: No publication reviews leading edge companies and technology better than START-UP. Each issue of START-UP profiles the most important new product companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing. Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics.

Includes FREE subscription to Health News Daily

Subscribe Subscribe w/ archive Renew Subscription Latest Issue Subscription Agreement Search Articles Sample Issue


The RPM Report: Regulation • Policy • Market Access
The RPM Report To help you make sense of the complicated and often arcane regulatory world, we have launched a new monthly publication, The RPM Report: Regulation, Policy and Market Access.
From the RPM Report, you'll get easy-to-understand, practical insight on the regulatory and policy issues you need to know. You'll learn the "so what" behind the latest from the FDA and CMS that you readily can apply to the success of your business. Learn more at therpmreport.com.

Includes FREE subscription to Health News Daily

Subscribe Subscribe w/ archive Renew Subscription Latest Issue Subscription Agreement Search Articles Sample Issue


Medtech Insight Newsletter
Medtech Insight Medtech Insight delivers the quality content you need on medical technologies impacting the spectrum of surgical, orthopedic, cardiovascular, and other markets. Written and edited by seasoned industry participants and experts, the Medtech Insight newsletter provides insights into the technology and market developments (devices, instrumentation, biomaterials, gene therapy, tissue engineering, etc.) impacting a wide range of surgical and non-surgical clinical practices (cardiothoracic & vascular surgery, general surgery, orthopedics & spine surgery, interventional radiology/cardiology, etc.). Learn more at www.medtechinsight.com.

Includes FREE subscription to Health News Daily

Subscribe Subscribe w/ archive Renew Subscription Latest Issue Subscription Agreement Search Articles Sample Issue


Medtech Insight Reports
MTI Reports Medtech Insight Reports are comprehensive analyses of the devices, technologies, procedures, and companies shaping the global medical technology market. We are the leading and most trusted provider of off-the-shelf medical technology market reports. To find out about upcoming reports, custom reports, or corporate intelligence subscriptions, contact reports@elsevier.com or call +1-949-453-0071. Learn more at www.medtechinsight.com.


Medical Devices Today
Medical Devices Today Medical Devices Today provides complimentary news articles, industry announcements and analysis of key developments in the medical device and diagnostics industries. Medical Devices Today was created to give readers access to some of the unique content from Elsevier Business Intelligence publications, including:

  • "The Gray Sheet"
  • Medtech Insight
  • "The Silver Sheet"
  • IN VIVO
  • Start-Up
  • Strategic Transactions
In addition to visiting the website, readers can sign up to receive a free weekly email update.


More industry leading publications from Elsevier Business Intelligence:

BioPharma Focus
"The Pink Sheet" | "The Pink Sheet" DAILY | "The Gold Sheet" | Health News Daily | PharmAsia News | Pharmaceutical Approvals Monthly

Medical Device Focus
"The Gray Sheet" | "The Silver Sheet" | Health News Daily

Consumer Focus
"The Rose Sheet" | "The Tan Sheet" | Health News Daily

The IN VIVO Blog

IN3 Europe + Investor Day
April 28-30, 2010 · Paris, France

IN3 East + Investor Day
June 9-11, 2010 · Boston, MA

Euro-Biotech Forum
June 28-30, 2010 · Paris, France

Interested in presenting at a Windhover conference?
Submit your idea here


Orphaned No Longer: Big Pharma Embraces Drugs for Niche Markets
Hit hard by late stage pipeline failures and the regulatory and reimbursement challenges of traditional primary care products, Big Pharmas are taking renewed interest in drugs for orphan diseases, where high unmet medical need offers the promise of premium pricing and there's potential to grow the market via approval in multiple indications. . . [MORE] (IN VIVO)

Despite Advances, Regenerative Medicine Faces Funding Crisis
Stem-cell and regenerative medicine firms are scrambling to find business models to harness the field's nascent, rapidly evolving science. Companies deep into clinical trials are still looking for pharma partnerships. . . [MORE] (Start-Up)

The Future of Drug-Eluting Stents Part II: Biodegradable Platforms
The safety profile of drug eluting stents appears to be improving with second and third-generation designs that utilize thinner struts (which are believed to reduce vessel injury and turbulent blood flow) and minimize or eliminate the polymer coating. . . [MORE] (Medtech Insight)

Health Reform in the Balance: What It Means for Biopharma
The long road to enacting health reform appeared to be close to an end with final negotiations taking place in the White House. But the Senate race for Ted Kennedy's open seat in Massachusetts has put the bill, and pharma's hard-fought concessions, in the breach. . . [MORE] (The RPM Report)

Read more from the latest: IN VIVO, Start-Up, The RPM Report, Medtech Insight, "The Pink Sheet", "The Pink Sheet" DAILY, "The Rose Sheet", "The Tan Sheet", PharmAsia News, Pharmaceutical Approvals Monthly, and "The Gray Sheet".




Pharma Deals
  FDA Has Full Plate This Fall for Vaccines: More Than H1N1
  GSK Slides Away From Innovation
  The Billion Dollar REMS: Xenazine?
Device Deals
  Stroke Devices: Facing Challenges Head On
  Vascular Closure Devices at the Crossroads
  What New Her2 Tests Say about Personalized Medicine

Interested in subscribing? Click here.
Publications - Databases - Conferences - About Us - Contact Us - Help - The IN VIVO Blog - RSS Feeds - Company Profiles - Subscriber Login

Copyright © 2010, Windhover Information, Inc. An Elsevier company. All rights reserved.

Elsevier Business Intelligence